Clearmind Medicine Inc. Common Shares (CMND) — Strategic Asset Allocation Index
Clearmind Medicine Inc. Common Shares (CMND) has a Strategic Asset Allocation Index of 0.3% as of July 2023. Strategic assets (PP&E of $7.30K plus long-term investments of $-) total $7.30K, measured against net assets of $2.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Clearmind Medicine Inc. Common Shares (CMND) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Clearmind Medicine Inc. Common Shares Strategic Asset Allocation Index (2018–2021)
This chart shows how Clearmind Medicine Inc. Common Shares's Strategic Asset Allocation Index has evolved across 3 annual periods from 2018 to 2021. As of July 2023, the index stands at 0.3%, representing strategic assets of $7.30K against net assets of $2.13 Million USD. See Clearmind Medicine Inc. Common Shares leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Clearmind Medicine Inc. Common Shares (2018–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Clearmind Medicine Inc. Common Shares from 2018 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Clearmind Medicine Inc. Common Shares (CMND) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.5% | $20.58K | $20.58K | $- | $3.87 Million | ▼ -171.3 pp |
| 2019 | 171.8% | $174.59K | $174.59K | $- | $101.63K | ▲ +81.5 pp |
| 2018 | 90.3% | $164.59K | $164.59K | $- | $182.24K | — |